NVAX - Novavax Stock Rallies In Pre-Market As Company Plans To Deliver Covid-19 Vaccine By September | Benzinga
Novavax Inc. (NASDAQ:NVAX) shares surged after the company announced its plans to deliver a regulator-recommended vaccine against a strain of Covid-19 by September.
What Happened: The Maryland-based biotechnology company’s shares were trading higher by 21.60% to $25.50 in premarket trading on Thursday, at the time of writing, following the announcement.
Novavax revealed that it is on track to deliver a vaccine against a Covid-19 strain recommended by a U.S. regulatory advisory group by September, MarketWatch reported. This announcement follows the U.S. Food and Drug Administration’s Vaccines and Related Biological Products Advisory Committee’s recommendation on Wednesday to ...